An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with glibenclamide as adjunctive therapy in patients with type 2 diabetes poorly controlled on metformin: Response to Barnett et al. [3] Letter uri icon

Overview

MeSH Major

  • Diabetes Mellitus, Type 2
  • Glyburide
  • Hypoglycemic Agents
  • Insulin

publication date

  • February 2007

Research

keywords

  • Letter

Identity

Digital Object Identifier (DOI)

  • 10.2337/dc06-2031

PubMed ID

  • 17259531

Additional Document Info

start page

  • 445

end page

  • 6; author reply 446

volume

  • 30

number

  • 2